Stocks and InvestingStocks and Investing
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021

Serge Belanger Maintained (TRVI) at Strong Buy with Decreased Target to $10 on, Aug 13th, 2021


Published on 2024-10-27 17:38:29 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Trevi Therapeutics, Inc." (TRVI) at Strong Buy with Decreased Target from $12 to $10 on, Aug 13th, 2021.

Serge, nor any peers, have made any analyst calls on TRVI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30